Cell / animal study· 2004
[The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation].
Bioorganicheskaia khimiia
Back to all molecules
Limited / uncertainNot FDA-approved
Semax
Synthetic ACTH-fragment analog
Also indexed as: ACTH 4-10 analog
What this evidence does not tell us
The linked receptor-binding study uses rat brain membranes; it is not a human cognition trial. Regional clinical reports require independent replication and appraisal.
Terms on this page
Unfamiliar word? Open this panel for simple explanations, right here.
7 glossary terms used in this profile
Terms on this page
Unfamiliar word? Open this panel for simple explanations, right here.
7 glossary terms used in this profile
Select a word to see its meaning. You can keep more than one definition open.
Definitions explain the words—not whether a molecule works or is safe. Research education only, not medical advice.
Overview
Semax is a synthetic peptide analog related to an ACTH fragment. This profile covers research context without assuming that laboratory findings establish cognitive or neurological treatment benefit.
Mechanism of action
ACTH-related / neurotrophic signaling
Laboratory research examines peptide binding, degradation and neurotrophic signaling associated with an ACTH-derived analog. The linked rat-brain study is not validation of human neurological benefit.
A biological pathway describes a proposed or observed interaction—not necessarily a demonstrated health outcome.
Decode the terminology in our glossaryScientific evidence
How strong is the evidence?
Not enough reliable evidence
- Limited evidenceCurrent category
- Early research
- Human research
- Human outcomes
There is too little dependable or verified research here to draw a useful conclusion about benefit in people.
For this research: The linked receptor-binding study uses rat brain membranes; it is not a human cognition trial. Regional clinical reports require independent replication and appraisal.
An editorial guide—not a validated score, a percentage, a safety rating or an approval badge. Regulatory status is separate. More research does not mean fewer risks.
Cell studies
The linked study examines binding and degradation in rat brain membrane preparations.
Animal experiments
Animal evidence is not separately assessed here. Findings in animals must not be interpreted as demonstrated human benefit.
Human observational studies
Associations, biomarker studies and anecdotes cannot establish treatment causality; no observational result is used here to infer clinical effectiveness.
Human clinical trials
Reliable, independently replicated human outcome evidence is not established by the selected sources in this edition.
Regulatory evidence
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Potential research applications
Neuropeptide signaling and neurological research hypotheses.
These describe scientific questions, not prescribing recommendations. A research grouping does not establish combination safety or clinical effectiveness.
Explore research by health goalSafety considerations
FDA identifies limited safety information and possible immunogenicity and peptide impurities. Long-term neurological effects and drug interactions remain uncertain.
This is not an exhaustive safety or contraindication list. An absence of reported harm is not proof of safety. Pregnancy, breastfeeding, cancer history, endocrine disease and concurrent medicines can materially change risk. Unregulated preparations add identity, contamination and sterility risks.
Read FDA’s compounding safety informationRegulatory status · United States
Not FDA-approved
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Regulatory status and evidence strength are different. A nomination for compounding, a clinical-trial registration or a “research use only” label is not approval. International rules vary; consult the current regulator and product label.
Selected literature & source transparency
Matched bibliographic records confirm a publication’s identity, not the validity of every claim. Selected sources are not a systematic literature review.
Continue your own source search
These open search results, not additional verified citations. Trial registration is not evidence that a treatment works.
Three questions worth bringing to your clinician
- Which human outcomes—not just biomarkers—support this claim?
- What established options address my actual health concern?
- What do my medical history and current medicines change about the risks?
Beyond the library
Turn better questions into a thoughtful conversation.
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Request an Optimization Consultation
Continue to our existing activation & intake page.